Skip to main content
. 2023 Sep 26;6(9):e2335797. doi: 10.1001/jamanetworkopen.2023.35797

Figure 1. Results of Subgroup Analyses With Events for the Association Between the Use of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) vs Dipeptidyl Peptidase 4 Inhibitors (DPP4i) and the Risk of Overall Fractures.

Figure 1.

HR indicates hazard ratio; IR, incidence rate; SSRI, selective serotonin reuptake inhibitor.